Targeted Disruption of Purine Biosynthesis Potently Inhibits Vaccinia Virus Replication In Vitro: A Mechanistic Study on the Antiviral Efficacy of 6-Mercaptopurine

Fuente: Zenodo
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Richardson, Alexander L
Format: Recurso digital
Sprache:Englisch
Veröffentlicht: Zenodo 2022
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1866901826355331072
author Richardson, Alexander L
author_facet Richardson, Alexander L
contents <p>This study provides a detailed investigation into the antiviral potential of 6-mercaptopurine (6-MP) against vaccinia virus <em>in vitro</em>. It demonstrates a potent, dose-dependent inhibition of viral replication, with near-complete suppression achieved at concentrations of 1.0–1.5 µg/mL, while host cell viability remains high. Mechanistic analysis reveals that 6-MP disrupts the viral life cycle by depleting purine nucleotide pools, leading to severe impairment of both viral DNA synthesis and late protein production. The findings establish a clear therapeutic window and confirm the vulnerability of large DNA viruses to host-directed metabolic inhibition, supporting the rationale for exploring purine synthesis inhibitors as broad-spectrum antivirals.</p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_18399308
institution Zenodo
language eng
publishDate 2022
publisher Zenodo
record_format zenodo
spellingShingle Targeted Disruption of Purine Biosynthesis Potently Inhibits Vaccinia Virus Replication In Vitro: A Mechanistic Study on the Antiviral Efficacy of 6-Mercaptopurine
Richardson, Alexander L
Vaccinia virus, 6-Mercaptopurine, Antiviral, Nucleotide metabolism, Purine synthesis inhibition, Host-directed therapy, Poxvirus
<p>This study provides a detailed investigation into the antiviral potential of 6-mercaptopurine (6-MP) against vaccinia virus <em>in vitro</em>. It demonstrates a potent, dose-dependent inhibition of viral replication, with near-complete suppression achieved at concentrations of 1.0–1.5 µg/mL, while host cell viability remains high. Mechanistic analysis reveals that 6-MP disrupts the viral life cycle by depleting purine nucleotide pools, leading to severe impairment of both viral DNA synthesis and late protein production. The findings establish a clear therapeutic window and confirm the vulnerability of large DNA viruses to host-directed metabolic inhibition, supporting the rationale for exploring purine synthesis inhibitors as broad-spectrum antivirals.</p>
title Targeted Disruption of Purine Biosynthesis Potently Inhibits Vaccinia Virus Replication In Vitro: A Mechanistic Study on the Antiviral Efficacy of 6-Mercaptopurine
topic Vaccinia virus, 6-Mercaptopurine, Antiviral, Nucleotide metabolism, Purine synthesis inhibition, Host-directed therapy, Poxvirus
url https://doi.org/10.5281/zenodo.18399308